XML 19 R4.htm IDEA: XBRL DOCUMENT v3.24.1
Consolidated Statements of Operations and Comprehensive Loss - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Income Statement [Abstract]    
Research and development expenses (Note 6) $ 4,704 $ 1,967
Marketing expenses 122
General and administrative expenses (Note 7) 2,278 2,465
Total operating expenses 7,104 4,432
Operating loss 7,104 4,432
Other expense 14
Finance income, net (7) (11)
Loss for the year 7,097 4,435
Other comprehensive loss (income):    
Foreign currency translation adjustment 1 (23)
Comprehensive loss for the year $ 7,098 $ 4,412
Basic loss per share $ 0.38 $ 0.29
Diluted loss per share $ 0.38 $ 0.29
Weighted average number of common stock outstanding used in computing basic net loss per share 20,760,266 15,474,600
Weighted average number of common stock outstanding used in computing diluted net loss per share 20,760,266 15,474,600